tfos dews II report

DEWS II
COMMITTEES

Now that we have launched the TFOS DEWS II, we would like to thank the experts who are participating in this global initiative. Every week for a period of 12 weeks we will thank those individuals serving on one of the 12 different Subcommittees. The Subcommittee meetings begin in June in Paris. The members are...

> Steering Committee

> Definition & Classification Subcommittee

> Epidemiology Subcommittee

> Iatrogenic Dry Eye Disease Subcommittee

> Pathophysiology Subcommittee

> Sex, Hormones & Gender Subcommittee

> Management & Therapy Subcommittee

> Clinical Trials Subcommittee

Novack, Gary (USA), President, Pharma•Logic Development, San Rafael, CA

Asbell, Penny (USA), Professor of Ophthalmology, and Director of the Cornea Service and Refractive Surgery Center, Mount Sinai School of Medicine, New York City

Barabino, Stefano (Italy), Associate Professor of Ophthalmology, University of Genoa

Bergamini, Michael (USA), Chief Scientific Officer / Executive Vice President, Nicox, and Adjunct Professor of Pharmacology & Neuroscience, University of North Texas Health Science Center, Fort Worth

Ciolino, Joseph (USA), Assistant Professor of Ophthalmology, Massachusetts Eye & Ear Infirmary and Harvard Medical School, Boston, MA

Foulks, Gary (USA), Emeritus Professor of Ophthalmology, University of Louisville School of Medicine, KY

Goldstein, Michael (USA), Co-Director of Cornea, External Diseases and Cataract Service at New England Eye Center, and Assistant Professor, Tufts University School of Medicine, Boston

Lemp, Michael (USA), Chief Medical Officer, Tear Lab Corporation, and Clinical Professor of Ophthalmology, Georgetown and George Washington Schools of Medicine

Schrader, Stefan (Germany), Professor and Head, Laboratory of Experimental Ophthalmology, Heinrich-Heine-University, Düsseldorf

Woods, Craig (Australia), Head of Clinical Partnerships and Associate Professor, Deakin Optometry, School of Medicine, Deakin University, Geelong Woods, Craig (Australia), Head of Clinical Partnerships and Associate Professor, Deakin Optometry, School of Medicine, Deakin University, Geelong

> Tear Film Subcommittee

> Diagnosis Subcommittee

> Pain & Sensation Subcommittee

> Public Awareness & Education Subcommittee

> Industry Liaison Subcommittee

 

 


 

Alcon

Novartis

Shire

Allergan

Bausch + Lomb

Akorn

Cooper Vision

Dompè

Horus

lubris

Oculeve

Sun Pharma

TearLab

Thea

Sifi

for Johnson & Johnson Vision Care

     

DEWS II
MISSION & OBJECTIVES

TFOS DEWS II will update the definition, classification and diagnosis of dry eye disease, critically assess the etiology, mechanism, distribution and global impact of this disorder, and address its management and therapy.

read on

DEWS II
NEWS

The TFOS DEWS II™ Report Special Interest Group will occur at the ARVO Annual Meeting on Sunday, May 7, from 1:30 – 3:00 pm in Ballroom 4 of the Baltimore Convention Center. 

read on

DEWS II
NEWS

TFOS DEWS II will update the definition, classification and diagnosis of dry eye disease, critically assess the etiology, mechanism, distribution and global impact of this disorder, and address its management and therapy. This report will be published in The Ocular Surface and the TFOS DEWS II members...

read on

 


TFOS
TEAR FILM & OCULAR SURFACE SOCIETY

TFOS is a world leader in eye health education.

TFOS' global collaboration among scientists, clinicians and industry professionals seeks action needed to help the world see better.

read on

tfos twitter account tfos linked in accounttfos youtube accounttfos blog account
 
 
TFOS Dew Report Homepage News Tfos Dews Report Sponsors Tfos Dews Report Timeline Tfos Dews Report  Objectives Tfos Dews Report Committees Tfos Dews Report